Кыргызстандын Саламаттык Сактоо
Zdravoohraneniye Kyrgyzstana

ISSN 1694-8068 (Print)

ISSN 1694-805X (Online)

Кирүү

COVID- 19догу нерв системасынын жабыркоосунун патофизиологиялык жана клиникалык аспектилери

https://doi.org/10.51350/zdravkg20219318
COVID- 19догу нерв системасынын жабыркоосунун патофизиологиялык жана клиникалык аспектилери
Полный текст Full text Толук текст  

PDF (RUS)

PDF (RUS)

PDF (RUS)
Корутунду Авторлор жөнүндө Шилтемелер

Корутунду

COVID-19 дем алуу жолдорунун жабыркашы жана башка органдар менен тутумдардын жабыркашы менен мүнөздөлөт. Анын бирден бир көбүрөөк клиникалык көрүнүштөрүнүн бири неврологиялык симптомдор. Бай- коодо бүгүнкү күндө COVID-19дун эң белгилүүсү болуп, неврологиялык жабыркоолор көрсөтүлгөн. Эң көп неврологиялык көрүнүштөрдүн ичинен миалгия, баш оору, энцефалопатия, баш айлануу, дизгевзия жана аносмия белгиленет. Менингит, энцефалит, энцефаломиелит, геморрагиялык некроздоочу энцефалопатия жана Гийен- Барре синдрому сыяктуу башка абалдарды беригип татаалдашкан COVID-19ге киргизсе болот. Кабылдагыч AПФ 2 менен SARS-CoV2 байланышынын жогорку окшоштугунун негизинде болгон ортомчу нейроинвазия COVID-19дун негизинде жатуучу патофизиологиялык аспектилер келтирилген.

Авторлор жөнүндө

Мамытова Элмира Миталиповна, д.м.н., доцент, заведующая кафедрой неврологии и
клинической генетики им. акад. Мурзалиева А.М. КГМА им. И.К. Ахунбаева, Бишкек, Кыргызская Республика

 

Mamytova Elmira Mitalipovna, Med.Sc., Associate Professor, Head of the Department of Neurology
and Clinical Genetics. acad. Murzalieva A.M. KSMA them. I.K. Akhunbaeva, Bishkek, Kyrgyz Republic 

Мамытова Элмира Миталиповна, медицина илимдеринин доктору, доцент, И.К. Ахунбаев атындагы КММАнын акад. Мурзалиев А.М. атындагы неврология жана клиникалык генетика кафедрасынын башчысы, Бишкек, Кыргыз Республикасы.

Шилтемелер

1. Oficialnii sait Ministerstva zdravoochranenia Kyrgyzskoi Respubliki. http://med.kg/ru/1

2. Oficialnii sait BBC. https://www.bbc.com/russian/news-51706538.

3. Tancheva L, Petralia MC, Miteva S, Dragomanova S, Solak A, Kalfin R, Lazarova M, Yarkov D, Ciurleo R, Cavalli E, Bramanti A, Nicoletti F. Emerging Neurological and Psychobiological Aspects of COVID-19 Infection. Brain Sci. 2020 Nov 12;10(11):852. doi: 10.3390/brainsci10110852. PMID: 33198412; PMCID: PMC7696269

4. Gupta, A., Madhavan, M.V., Sehgal, K. et al. Extrapulmonary manifestations of COVID-19. Nat Med 26, 1017–1032 (2020). https://doi.org/10.1038/s41591-020-0968-3

5. Nepal, G., Rehrig, J.H., Shrestha, G.S. et al. Neurological manifestations of COVID-19: a systematic review. Crit Care 24, 421 (2020). https://doi.org/10.1186/s13054-020-03121-z

6. Brann DH, Tsukahara T, Weinreb C, Logan DW, Datta SR. Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients. bioRxiv Preprint. 2020. Available at 10.1101/2020.03.25.009084.

7. Conde Cardona G, Quintana Pájaro LD, Quintero Marzola ID, Ramos Villegas Y, Moscote Salazar LR. Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J Neurol Sci. 2020;412:116824. 10.1016/j.jns.2020.116824. - PMC - PubMed

8. Monteleone G, Sarzi-Puttini PC, Ardizzone S. Preventing COVID-19-induced pneumonia with anticytokine therapy. Lancet Rheumatol. 2020;2(5):e255–6. - PMC - PubMed

9. Nath A. Neurologic complications of coronavirus infections. Neurology. 2020;94(19):809–10. - PubMed

10. Liotta, E.M., Batra, A., Clark, J.R., Shlobin, N.A., Hoffman, S.C., Orban, Z.S. and Koralnik, I.J. (2020), Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients. Ann Clin Transl Neurol, 7: 2221-2230. https://doi.org/10.1002/acn3.51210

11. Shen Z, Xiao Y, Kang L, et al. Genomic diversity of SARS‐CoV‐2 in Coronavirus Disease 2019 patients. Clin Infect Dis2020; 71(15): 713– 720. https://dio.org/10.1093/cid/ciaa203

12. García‐Azorín D, Martínez‐Pías E, Trigo J, et al. Neurological comorbidity is a predictor of death in Covid‐19 disease: a cohort study on 576 patients. Front Neurolo 2020; 11: 781. https://dio.org/10.3389/fneur.2020.00781

13. Davies NWS, Sharief MK, Howard RS. Infection–associated encephalopathies—their investigation, diagnosis, and treatment. J Neurol 2006; 253: 833– 845.

14. WHO Coronavirus Disease (COVID‐19) Dashboard. Geneva: World Health Organization; 2020 [7/28/2020]; Available from: https://covid19.who.int/.

15. Li, Y., Li, M., Wang, M., Zhou, Y., Chang, J., Xian, Y., Wang, D., Mao, L., Jin, H., & Hu, B. (2020). Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke and Vascular Neurology, 5(3), 279–284. https://doi.org/10.1136/svn-2020-000431.

16Reichard, R. R., Kashani, K. B., Boire, N. A., Constantopoulos, E., Guo, Y., & Lucchinetti, C. F. (2020). Neuropathology of COVID-19: A spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathologica, 140(1), 1–6.

17. Parsons, T., Banks, S., Bae, C., Gelber, J., Alahmadi, H., & Tichauer, M. (2020). COVID-19-associated acute disseminated encephalomyelitis (ADEM). Journal of Neurology, 267(10), 2799–2802. https://doi.org/10.1007/s00415-020-09951-9.

18. Pilotto, A., Odolini, S., Masciocchi, S., Comelli, A., Volonghi, I., Gazzina, S., et al. (2020). Steroid-Responsive Encephalitis in Coronavirus Disease 2019. Annals of Neurology. https://doi.org/10.1002/ana.25783.

19. Camdessanche, J. P., Morel, J., Pozzetto, B., Paul, S., Tholance, Y., & Botelho-Nevers, E. (2020). COVID-19 may induce Guillain-Barre syndrome. Revue Neurologique (Paris), 176

20. Beydon, M., Chevalier, K., Al Tabaa, O., Hamroun, S., Delettre, A.-S., Thomas, M., Mariette, X. (2020). Myositis as a manifestation of SARS-CoV-2. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-217573.

21. Jin, M., & Tong, Q. (2020). Rhabdomyolysis as potential late complication associated with COVID-19. Emerging Infectious Diseases, 26(7). https://doi.org/10.3201/eid2607.200445.

 

1. Oficialnii sait Ministerstva zdravoochranenia Kyrgyzskoi Respubliki. http://med.kg/ru/1

2. Oficialnii sait BBC. https://www.bbc.com/russian/news-51706538.

3. Tancheva L, Petralia MC, Miteva S, Dragomanova S, Solak A, Kalfin R, Lazarova M, Yarkov D, Ciurleo R, Cavalli E, Bramanti A, Nicoletti F. Emerging Neurological and Psychobiological Aspects of COVID-19 Infection. Brain Sci. 2020 Nov 12;10(11):852. doi: 10.3390/brainsci10110852. PMID: 33198412; PMCID: PMC7696269

4. Gupta, A., Madhavan, M.V., Sehgal, K. et al. Extrapulmonary manifestations of COVID-19. Nat Med 26, 1017–1032 (2020). https://doi.org/10.1038/s41591-020-0968-3

5. Nepal, G., Rehrig, J.H., Shrestha, G.S. et al. Neurological manifestations of COVID-19: a systematic review. Crit Care 24, 421 (2020). https://doi.org/10.1186/s13054-020-03121-z

6. Brann DH, Tsukahara T, Weinreb C, Logan DW, Datta SR. Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients. bioRxiv Preprint. 2020. Available at 10.1101/2020.03.25.009084.

7. Conde Cardona G, Quintana Pájaro LD, Quintero Marzola ID, Ramos Villegas Y, Moscote Salazar LR. Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J Neurol Sci. 2020;412:116824. 10.1016/j.jns.2020.116824. - PMC - PubMed

8. Monteleone G, Sarzi-Puttini PC, Ardizzone S. Preventing COVID-19-induced pneumonia with anticytokine therapy. Lancet Rheumatol. 2020;2(5):e255–6. - PMC - PubMed

9. Nath A. Neurologic complications of coronavirus infections. Neurology. 2020;94(19):809–10. - PubMed

10. Liotta, E.M., Batra, A., Clark, J.R., Shlobin, N.A., Hoffman, S.C., Orban, Z.S. and Koralnik, I.J. (2020), Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients. Ann Clin Transl Neurol, 7: 2221-2230. https://doi.org/10.1002/acn3.51210

11. Shen Z, Xiao Y, Kang L, et al. Genomic diversity of SARS‐CoV‐2 in Coronavirus Disease 2019 patients. Clin Infect Dis2020; 71(15): 713– 720. https://dio.org/10.1093/cid/ciaa203

12. García‐Azorín D, Martínez‐Pías E, Trigo J, et al. Neurological comorbidity is a predictor of death in Covid‐19 disease: a cohort study on 576 patients. Front Neurolo 2020; 11: 781. https://dio.org/10.3389/fneur.2020.00781

13. Davies NWS, Sharief MK, Howard RS. Infection–associated encephalopathies—their investigation, diagnosis, and treatment. J Neurol 2006; 253: 833– 845.

14. WHO Coronavirus Disease (COVID‐19) Dashboard. Geneva: World Health Organization; 2020 [7/28/2020]; Available from: https://covid19.who.int/.

15. Li, Y., Li, M., Wang, M., Zhou, Y., Chang, J., Xian, Y., Wang, D., Mao, L., Jin, H., & Hu, B. (2020). Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke and Vascular Neurology, 5(3), 279–284. https://doi.org/10.1136/svn-2020-000431.

16Reichard, R. R., Kashani, K. B., Boire, N. A., Constantopoulos, E., Guo, Y., & Lucchinetti, C. F. (2020). Neuropathology of COVID-19: A spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathologica, 140(1), 1–6.

17. Parsons, T., Banks, S., Bae, C., Gelber, J., Alahmadi, H., & Tichauer, M. (2020). COVID-19-associated acute disseminated encephalomyelitis (ADEM). Journal of Neurology, 267(10), 2799–2802. https://doi.org/10.1007/s00415-020-09951-9.

18. Pilotto, A., Odolini, S., Masciocchi, S., Comelli, A., Volonghi, I., Gazzina, S., et al. (2020). Steroid-Responsive Encephalitis in Coronavirus Disease 2019. Annals of Neurology. https://doi.org/10.1002/ana.25783.

19. Camdessanche, J. P., Morel, J., Pozzetto, B., Paul, S., Tholance, Y., & Botelho-Nevers, E. (2020). COVID-19 may induce Guillain-Barre syndrome. Revue Neurologique (Paris), 176

20. Beydon, M., Chevalier, K., Al Tabaa, O., Hamroun, S., Delettre, A.-S., Thomas, M., Mariette, X. (2020). Myositis as a manifestation of SARS-CoV-2. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-217573.

21. Jin, M., & Tong, Q. (2020). Rhabdomyolysis as potential late complication associated with COVID-19. Emerging Infectious Diseases, 26(7). https://doi.org/10.3201/eid2607.200445.

 

1. Oficialnii sait Ministerstva zdravoochranenia Kyrgyzskoi Respubliki. http://med.kg/ru/1

2. Oficialnii sait BBC. https://www.bbc.com/russian/news-51706538.

3. Tancheva L, Petralia MC, Miteva S, Dragomanova S, Solak A, Kalfin R, Lazarova M, Yarkov D, Ciurleo R, Cavalli E, Bramanti A, Nicoletti F. Emerging Neurological and Psychobiological Aspects of COVID-19 Infection. Brain Sci. 2020 Nov 12;10(11):852. doi: 10.3390/brainsci10110852. PMID: 33198412; PMCID: PMC7696269

4. Gupta, A., Madhavan, M.V., Sehgal, K. et al. Extrapulmonary manifestations of COVID-19. Nat Med 26, 1017–1032 (2020). https://doi.org/10.1038/s41591-020-0968-3

5. Nepal, G., Rehrig, J.H., Shrestha, G.S. et al. Neurological manifestations of COVID-19: a systematic review. Crit Care 24, 421 (2020). https://doi.org/10.1186/s13054-020-03121-z

6. Brann DH, Tsukahara T, Weinreb C, Logan DW, Datta SR. Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients. bioRxiv Preprint. 2020. Available at 10.1101/2020.03.25.009084.

7. Conde Cardona G, Quintana Pájaro LD, Quintero Marzola ID, Ramos Villegas Y, Moscote Salazar LR. Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J Neurol Sci. 2020;412:116824. 10.1016/j.jns.2020.116824. - PMC - PubMed

8. Monteleone G, Sarzi-Puttini PC, Ardizzone S. Preventing COVID-19-induced pneumonia with anticytokine therapy. Lancet Rheumatol. 2020;2(5):e255–6. - PMC - PubMed

9. Nath A. Neurologic complications of coronavirus infections. Neurology. 2020;94(19):809–10. - PubMed

10. Liotta, E.M., Batra, A., Clark, J.R., Shlobin, N.A., Hoffman, S.C., Orban, Z.S. and Koralnik, I.J. (2020), Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients. Ann Clin Transl Neurol, 7: 2221-2230. https://doi.org/10.1002/acn3.51210

11. Shen Z, Xiao Y, Kang L, et al. Genomic diversity of SARS‐CoV‐2 in Coronavirus Disease 2019 patients. Clin Infect Dis2020; 71(15): 713– 720. https://dio.org/10.1093/cid/ciaa203

12. García‐Azorín D, Martínez‐Pías E, Trigo J, et al. Neurological comorbidity is a predictor of death in Covid‐19 disease: a cohort study on 576 patients. Front Neurolo 2020; 11: 781. https://dio.org/10.3389/fneur.2020.00781

13. Davies NWS, Sharief MK, Howard RS. Infection–associated encephalopathies—their investigation, diagnosis, and treatment. J Neurol 2006; 253: 833– 845.

14. WHO Coronavirus Disease (COVID‐19) Dashboard. Geneva: World Health Organization; 2020 [7/28/2020]; Available from: https://covid19.who.int/.

15. Li, Y., Li, M., Wang, M., Zhou, Y., Chang, J., Xian, Y., Wang, D., Mao, L., Jin, H., & Hu, B. (2020). Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke and Vascular Neurology, 5(3), 279–284. https://doi.org/10.1136/svn-2020-000431.

16Reichard, R. R., Kashani, K. B., Boire, N. A., Constantopoulos, E., Guo, Y., & Lucchinetti, C. F. (2020). Neuropathology of COVID-19: A spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathologica, 140(1), 1–6.

17. Parsons, T., Banks, S., Bae, C., Gelber, J., Alahmadi, H., & Tichauer, M. (2020). COVID-19-associated acute disseminated encephalomyelitis (ADEM). Journal of Neurology, 267(10), 2799–2802. https://doi.org/10.1007/s00415-020-09951-9.

18. Pilotto, A., Odolini, S., Masciocchi, S., Comelli, A., Volonghi, I., Gazzina, S., et al. (2020). Steroid-Responsive Encephalitis in Coronavirus Disease 2019. Annals of Neurology. https://doi.org/10.1002/ana.25783.

19. Camdessanche, J. P., Morel, J., Pozzetto, B., Paul, S., Tholance, Y., & Botelho-Nevers, E. (2020). COVID-19 may induce Guillain-Barre syndrome. Revue Neurologique (Paris), 176

20. Beydon, M., Chevalier, K., Al Tabaa, O., Hamroun, S., Delettre, A.-S., Thomas, M., Mariette, X. (2020). Myositis as a manifestation of SARS-CoV-2. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-217573.

21. Jin, M., & Tong, Q. (2020). Rhabdomyolysis as potential late complication associated with COVID-19. Emerging Infectious Diseases, 26(7). https://doi.org/10.3201/eid2607.200445.

 

Для цитирования

Мамытова Э.М. Патофизиологические и клинические аспекты поражения нервной системы при КОВИД-19. Здравоохранение Кыргызстана 2021, № 3, с. 8- 15;

https://doi.org/10.51350/zdravkg20219318
For citation

Mamytova E.M. Pathophysiological and Clinical aspects of Nervous System affection in COVID-19.Health care of Kyrgyzstan 2021, no 3, pp. 8- 15;

https://doi.org/10.51350/zdravkg20219318
Цитата үчүн

Мамытова Э.М., КОВИД - 19догу нерв системасынын жабыркоосунун патофизиологиялык жана клиникалык
аспектилери. Кыргызстандын Cаламаттык Cактоо 2021, № 3, б. 8-15;
https://doi.org/10.51350/zdravkg20219318
Авторлор Мамытова Э.М.
Ссылка doi.org https://doi.org/10.51350/zdravkg20219318
Беттер 8-15
Орусча
Об авторах

Мамытова Элмира Миталиповна, д.м.н., доцент, заведующая кафедрой неврологии и
клинической генетики им. акад. Мурзалиева А.М. КГМА им. И.К. Ахунбаева, Бишкек, Кыргызская Республика

 
Полный текст

PDF (RUS)
Список литературы

1. Oficialnii sait Ministerstva zdravoochranenia Kyrgyzskoi Respubliki. http://med.kg/ru/1

2. Oficialnii sait BBC. https://www.bbc.com/russian/news-51706538.

3. Tancheva L, Petralia MC, Miteva S, Dragomanova S, Solak A, Kalfin R, Lazarova M, Yarkov D, Ciurleo R, Cavalli E, Bramanti A, Nicoletti F. Emerging Neurological and Psychobiological Aspects of COVID-19 Infection. Brain Sci. 2020 Nov 12;10(11):852. doi: 10.3390/brainsci10110852. PMID: 33198412; PMCID: PMC7696269

4. Gupta, A., Madhavan, M.V., Sehgal, K. et al. Extrapulmonary manifestations of COVID-19. Nat Med 26, 1017–1032 (2020). https://doi.org/10.1038/s41591-020-0968-3

5. Nepal, G., Rehrig, J.H., Shrestha, G.S. et al. Neurological manifestations of COVID-19: a systematic review. Crit Care 24, 421 (2020). https://doi.org/10.1186/s13054-020-03121-z

6. Brann DH, Tsukahara T, Weinreb C, Logan DW, Datta SR. Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients. bioRxiv Preprint. 2020. Available at 10.1101/2020.03.25.009084.

7. Conde Cardona G, Quintana Pájaro LD, Quintero Marzola ID, Ramos Villegas Y, Moscote Salazar LR. Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J Neurol Sci. 2020;412:116824. 10.1016/j.jns.2020.116824. - PMC - PubMed

8. Monteleone G, Sarzi-Puttini PC, Ardizzone S. Preventing COVID-19-induced pneumonia with anticytokine therapy. Lancet Rheumatol. 2020;2(5):e255–6. - PMC - PubMed

9. Nath A. Neurologic complications of coronavirus infections. Neurology. 2020;94(19):809–10. - PubMed

10. Liotta, E.M., Batra, A., Clark, J.R., Shlobin, N.A., Hoffman, S.C., Orban, Z.S. and Koralnik, I.J. (2020), Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients. Ann Clin Transl Neurol, 7: 2221-2230. https://doi.org/10.1002/acn3.51210

11. Shen Z, Xiao Y, Kang L, et al. Genomic diversity of SARS‐CoV‐2 in Coronavirus Disease 2019 patients. Clin Infect Dis2020; 71(15): 713– 720. https://dio.org/10.1093/cid/ciaa203

12. García‐Azorín D, Martínez‐Pías E, Trigo J, et al. Neurological comorbidity is a predictor of death in Covid‐19 disease: a cohort study on 576 patients. Front Neurolo 2020; 11: 781. https://dio.org/10.3389/fneur.2020.00781

13. Davies NWS, Sharief MK, Howard RS. Infection–associated encephalopathies—their investigation, diagnosis, and treatment. J Neurol 2006; 253: 833– 845.

14. WHO Coronavirus Disease (COVID‐19) Dashboard. Geneva: World Health Organization; 2020 [7/28/2020]; Available from: https://covid19.who.int/.

15. Li, Y., Li, M., Wang, M., Zhou, Y., Chang, J., Xian, Y., Wang, D., Mao, L., Jin, H., & Hu, B. (2020). Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke and Vascular Neurology, 5(3), 279–284. https://doi.org/10.1136/svn-2020-000431.

16Reichard, R. R., Kashani, K. B., Boire, N. A., Constantopoulos, E., Guo, Y., & Lucchinetti, C. F. (2020). Neuropathology of COVID-19: A spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathologica, 140(1), 1–6.

17. Parsons, T., Banks, S., Bae, C., Gelber, J., Alahmadi, H., & Tichauer, M. (2020). COVID-19-associated acute disseminated encephalomyelitis (ADEM). Journal of Neurology, 267(10), 2799–2802. https://doi.org/10.1007/s00415-020-09951-9.

18. Pilotto, A., Odolini, S., Masciocchi, S., Comelli, A., Volonghi, I., Gazzina, S., et al. (2020). Steroid-Responsive Encephalitis in Coronavirus Disease 2019. Annals of Neurology. https://doi.org/10.1002/ana.25783.

19. Camdessanche, J. P., Morel, J., Pozzetto, B., Paul, S., Tholance, Y., & Botelho-Nevers, E. (2020). COVID-19 may induce Guillain-Barre syndrome. Revue Neurologique (Paris), 176

20. Beydon, M., Chevalier, K., Al Tabaa, O., Hamroun, S., Delettre, A.-S., Thomas, M., Mariette, X. (2020). Myositis as a manifestation of SARS-CoV-2. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-217573.

21. Jin, M., & Tong, Q. (2020). Rhabdomyolysis as potential late complication associated with COVID-19. Emerging Infectious Diseases, 26(7). https://doi.org/10.3201/eid2607.200445.

 
Для цитирования

Мамытова Э.М. Патофизиологические и клинические аспекты поражения нервной системы при КОВИД-19. Здравоохранение Кыргызстана 2021, № 3, с. 8- 15;

https://doi.org/10.51350/zdravkg20219318
Англисче
About authors

Mamytova Elmira Mitalipovna, Med.Sc., Associate Professor, Head of the Department of Neurology
and Clinical Genetics. acad. Murzalieva A.M. KSMA them. I.K. Akhunbaeva, Bishkek, Kyrgyz Republic 
Full text

PDF (RUS)
References

1. Oficialnii sait Ministerstva zdravoochranenia Kyrgyzskoi Respubliki. http://med.kg/ru/1

2. Oficialnii sait BBC. https://www.bbc.com/russian/news-51706538.

3. Tancheva L, Petralia MC, Miteva S, Dragomanova S, Solak A, Kalfin R, Lazarova M, Yarkov D, Ciurleo R, Cavalli E, Bramanti A, Nicoletti F. Emerging Neurological and Psychobiological Aspects of COVID-19 Infection. Brain Sci. 2020 Nov 12;10(11):852. doi: 10.3390/brainsci10110852. PMID: 33198412; PMCID: PMC7696269

4. Gupta, A., Madhavan, M.V., Sehgal, K. et al. Extrapulmonary manifestations of COVID-19. Nat Med 26, 1017–1032 (2020). https://doi.org/10.1038/s41591-020-0968-3

5. Nepal, G., Rehrig, J.H., Shrestha, G.S. et al. Neurological manifestations of COVID-19: a systematic review. Crit Care 24, 421 (2020). https://doi.org/10.1186/s13054-020-03121-z

6. Brann DH, Tsukahara T, Weinreb C, Logan DW, Datta SR. Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients. bioRxiv Preprint. 2020. Available at 10.1101/2020.03.25.009084.

7. Conde Cardona G, Quintana Pájaro LD, Quintero Marzola ID, Ramos Villegas Y, Moscote Salazar LR. Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J Neurol Sci. 2020;412:116824. 10.1016/j.jns.2020.116824. - PMC - PubMed

8. Monteleone G, Sarzi-Puttini PC, Ardizzone S. Preventing COVID-19-induced pneumonia with anticytokine therapy. Lancet Rheumatol. 2020;2(5):e255–6. - PMC - PubMed

9. Nath A. Neurologic complications of coronavirus infections. Neurology. 2020;94(19):809–10. - PubMed

10. Liotta, E.M., Batra, A., Clark, J.R., Shlobin, N.A., Hoffman, S.C., Orban, Z.S. and Koralnik, I.J. (2020), Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients. Ann Clin Transl Neurol, 7: 2221-2230. https://doi.org/10.1002/acn3.51210

11. Shen Z, Xiao Y, Kang L, et al. Genomic diversity of SARS‐CoV‐2 in Coronavirus Disease 2019 patients. Clin Infect Dis2020; 71(15): 713– 720. https://dio.org/10.1093/cid/ciaa203

12. García‐Azorín D, Martínez‐Pías E, Trigo J, et al. Neurological comorbidity is a predictor of death in Covid‐19 disease: a cohort study on 576 patients. Front Neurolo 2020; 11: 781. https://dio.org/10.3389/fneur.2020.00781

13. Davies NWS, Sharief MK, Howard RS. Infection–associated encephalopathies—their investigation, diagnosis, and treatment. J Neurol 2006; 253: 833– 845.

14. WHO Coronavirus Disease (COVID‐19) Dashboard. Geneva: World Health Organization; 2020 [7/28/2020]; Available from: https://covid19.who.int/.

15. Li, Y., Li, M., Wang, M., Zhou, Y., Chang, J., Xian, Y., Wang, D., Mao, L., Jin, H., & Hu, B. (2020). Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke and Vascular Neurology, 5(3), 279–284. https://doi.org/10.1136/svn-2020-000431.

16Reichard, R. R., Kashani, K. B., Boire, N. A., Constantopoulos, E., Guo, Y., & Lucchinetti, C. F. (2020). Neuropathology of COVID-19: A spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathologica, 140(1), 1–6.

17. Parsons, T., Banks, S., Bae, C., Gelber, J., Alahmadi, H., & Tichauer, M. (2020). COVID-19-associated acute disseminated encephalomyelitis (ADEM). Journal of Neurology, 267(10), 2799–2802. https://doi.org/10.1007/s00415-020-09951-9.

18. Pilotto, A., Odolini, S., Masciocchi, S., Comelli, A., Volonghi, I., Gazzina, S., et al. (2020). Steroid-Responsive Encephalitis in Coronavirus Disease 2019. Annals of Neurology. https://doi.org/10.1002/ana.25783.

19. Camdessanche, J. P., Morel, J., Pozzetto, B., Paul, S., Tholance, Y., & Botelho-Nevers, E. (2020). COVID-19 may induce Guillain-Barre syndrome. Revue Neurologique (Paris), 176

20. Beydon, M., Chevalier, K., Al Tabaa, O., Hamroun, S., Delettre, A.-S., Thomas, M., Mariette, X. (2020). Myositis as a manifestation of SARS-CoV-2. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-217573.

21. Jin, M., & Tong, Q. (2020). Rhabdomyolysis as potential late complication associated with COVID-19. Emerging Infectious Diseases, 26(7). https://doi.org/10.3201/eid2607.200445.

 
For citation

Mamytova E.M. Pathophysiological and Clinical aspects of Nervous System affection in COVID-19.Health care of Kyrgyzstan 2021, no 3, pp. 8- 15;

https://doi.org/10.51350/zdravkg20219318
Кыргызча
Авторлор жөнүндө

Мамытова Элмира Миталиповна, медицина илимдеринин доктору, доцент, И.К. Ахунбаев атындагы КММАнын акад. Мурзалиев А.М. атындагы неврология жана клиникалык генетика кафедрасынын башчысы, Бишкек, Кыргыз Республикасы.
Толук текст

PDF (RUS)
Шилтемелер

1. Oficialnii sait Ministerstva zdravoochranenia Kyrgyzskoi Respubliki. http://med.kg/ru/1

2. Oficialnii sait BBC. https://www.bbc.com/russian/news-51706538.

3. Tancheva L, Petralia MC, Miteva S, Dragomanova S, Solak A, Kalfin R, Lazarova M, Yarkov D, Ciurleo R, Cavalli E, Bramanti A, Nicoletti F. Emerging Neurological and Psychobiological Aspects of COVID-19 Infection. Brain Sci. 2020 Nov 12;10(11):852. doi: 10.3390/brainsci10110852. PMID: 33198412; PMCID: PMC7696269

4. Gupta, A., Madhavan, M.V., Sehgal, K. et al. Extrapulmonary manifestations of COVID-19. Nat Med 26, 1017–1032 (2020). https://doi.org/10.1038/s41591-020-0968-3

5. Nepal, G., Rehrig, J.H., Shrestha, G.S. et al. Neurological manifestations of COVID-19: a systematic review. Crit Care 24, 421 (2020). https://doi.org/10.1186/s13054-020-03121-z

6. Brann DH, Tsukahara T, Weinreb C, Logan DW, Datta SR. Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients. bioRxiv Preprint. 2020. Available at 10.1101/2020.03.25.009084.

7. Conde Cardona G, Quintana Pájaro LD, Quintero Marzola ID, Ramos Villegas Y, Moscote Salazar LR. Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J Neurol Sci. 2020;412:116824. 10.1016/j.jns.2020.116824. - PMC - PubMed

8. Monteleone G, Sarzi-Puttini PC, Ardizzone S. Preventing COVID-19-induced pneumonia with anticytokine therapy. Lancet Rheumatol. 2020;2(5):e255–6. - PMC - PubMed

9. Nath A. Neurologic complications of coronavirus infections. Neurology. 2020;94(19):809–10. - PubMed

10. Liotta, E.M., Batra, A., Clark, J.R., Shlobin, N.A., Hoffman, S.C., Orban, Z.S. and Koralnik, I.J. (2020), Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients. Ann Clin Transl Neurol, 7: 2221-2230. https://doi.org/10.1002/acn3.51210

11. Shen Z, Xiao Y, Kang L, et al. Genomic diversity of SARS‐CoV‐2 in Coronavirus Disease 2019 patients. Clin Infect Dis2020; 71(15): 713– 720. https://dio.org/10.1093/cid/ciaa203

12. García‐Azorín D, Martínez‐Pías E, Trigo J, et al. Neurological comorbidity is a predictor of death in Covid‐19 disease: a cohort study on 576 patients. Front Neurolo 2020; 11: 781. https://dio.org/10.3389/fneur.2020.00781

13. Davies NWS, Sharief MK, Howard RS. Infection–associated encephalopathies—their investigation, diagnosis, and treatment. J Neurol 2006; 253: 833– 845.

14. WHO Coronavirus Disease (COVID‐19) Dashboard. Geneva: World Health Organization; 2020 [7/28/2020]; Available from: https://covid19.who.int/.

15. Li, Y., Li, M., Wang, M., Zhou, Y., Chang, J., Xian, Y., Wang, D., Mao, L., Jin, H., & Hu, B. (2020). Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke and Vascular Neurology, 5(3), 279–284. https://doi.org/10.1136/svn-2020-000431.

16Reichard, R. R., Kashani, K. B., Boire, N. A., Constantopoulos, E., Guo, Y., & Lucchinetti, C. F. (2020). Neuropathology of COVID-19: A spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathologica, 140(1), 1–6.

17. Parsons, T., Banks, S., Bae, C., Gelber, J., Alahmadi, H., & Tichauer, M. (2020). COVID-19-associated acute disseminated encephalomyelitis (ADEM). Journal of Neurology, 267(10), 2799–2802. https://doi.org/10.1007/s00415-020-09951-9.

18. Pilotto, A., Odolini, S., Masciocchi, S., Comelli, A., Volonghi, I., Gazzina, S., et al. (2020). Steroid-Responsive Encephalitis in Coronavirus Disease 2019. Annals of Neurology. https://doi.org/10.1002/ana.25783.

19. Camdessanche, J. P., Morel, J., Pozzetto, B., Paul, S., Tholance, Y., & Botelho-Nevers, E. (2020). COVID-19 may induce Guillain-Barre syndrome. Revue Neurologique (Paris), 176

20. Beydon, M., Chevalier, K., Al Tabaa, O., Hamroun, S., Delettre, A.-S., Thomas, M., Mariette, X. (2020). Myositis as a manifestation of SARS-CoV-2. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-217573.

21. Jin, M., & Tong, Q. (2020). Rhabdomyolysis as potential late complication associated with COVID-19. Emerging Infectious Diseases, 26(7). https://doi.org/10.3201/eid2607.200445.

 
Цитата үчүн

Мамытова Э.М., КОВИД - 19догу нерв системасынын жабыркоосунун патофизиологиялык жана клиникалык
аспектилери. Кыргызстандын Cаламаттык Cактоо 2021, № 3, б. 8-15;
https://doi.org/10.51350/zdravkg20219318
Көрүүлөр: 3284
Copyright MAXXmarketing GmbH
JoomShopping Download & Support